Login

Financial Snapshot

Revenue
TTM
$635.9M
Gross Margin
TTM
59.11%
Net Income
TTM
$171.9M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
673.72%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
494.0M
Cash
2026 Q1
P/E
TTM
14.01
Free Cash Flow
TTM
$150.4M

Stock Price

Loading...
Market Cap: $2.4085 Billion

About Transmedics Group Inc

TransMedics Group, Inc. operates as a commercial stage medical technology company. The company is headquartered in Andover, Massachusetts and currently employs 898 full-time employees. The company went IPO on 2019-05-02. The firm specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. The company also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Abbott Laboratories AtriCure Inc Cryoport Inc Integer Holdings Corp LeMaitre Vascular Inc NEVRO CORP Paragon 28, Inc. Procept Biorobotics Corp Treace Medical Concepts, Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support